Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

•During the COVID-19 pandemic, 97% of U.S. cystic fibrosis care programs used telehealth.•As the pandemic progressed, in-person visits supplanted telehealth visits.•Programs thought that lack of internet access was a major barrier to patient and family engagement with telehealth.•Programs reported that the quality of telehealth could be improved by expanded provision of remote monitoring devices and better access to technology.•Pediatric programs were less likely than adult programs to recommend telehealth.